News & Media

Take a closer look at what we’re doing across Teva in Canada and worldwide

Teva Canada Limited, headquartered in Toronto, and Teva Canada Innovation, headquartered in Montréal, are part of Teva Pharmaceutical Industries Ltd., the world’s largest generic drug maker. We’re proud to have been part of Canadian healthcare for more than 50 years, to market more than 400 medications across the country and to employ more than 1,000 Canadians.

If you’re looking for information about our company, please contact Public Affairs at Teva Canada Limited at Public.Affairs@tevacanada.com.

Latest news

Read the latest Teva news

Teva Canada announces new General Manager, Michael Sine

Teva Canada announces new General Manager, Michael Sine

Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, join a growing list of prov...

Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, join a growing list of provinces providing public drug plan reimbursement for Teva Canada’s AJOVY® (fremanezumab), for the preventive treatment of migraine in adults

New public drug plan reimbursement for AJOVY®

New public drug plan reimbursement for AJOVY®

Important Information – Voluntary Nationwide Recall - Novo-Gesic Forte® 500 mg (Acetaminophen) Table...

Important Information – Voluntary Nationwide Recall - Novo-Gesic Forte® 500 mg (Acetaminophen) Tablets

Teva Canada Provides New Patient Resource to Empower Those Living with Chronic Conditions

Teva Canada Provides New Patient Resource to Empower Those Living with Chronic Conditions

Teva Canada Welcomes Efforts to Address Critical Drug Supply in the Federal Budget

Teva Canada Welcomes Efforts to Address Critical Drug Supply in the Federal Budget

Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults

Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults

Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatme...

Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma

Important safety information on prescription cough and cold products containing opioids and the risk...

Important safety information on prescription cough and cold products containing opioids and the risk of opioid ase disorder in children and adolescents

Teva Canada announces product availability of AJOVY™

Teva Canada announces product availability of AJOVY™
View all news articles
Previous
Next

Featured stories

Meet Mathi Mathivanan, Teva Canada employee for 28 years

Meet Mathi Mathivanan, Teva Canada employee for 28 years

Meet Gina Cameron, Teva Canada Employee for 10 years!

Meet Gina Cameron, Teva Canada Employee for 10 years!

Meet Sandy Lee, Teva Canada Employee for 34 years

Meet Sandy Lee, Teva Canada Employee for 34 years

Meet Suzanne Brand, Senior Finance Director at Teva Canada

Meet Suzanne Brand, Senior Finance Director at Teva Canada

Meet Julien Dery, Sales Representative at Teva Canada

Meet Julien Dery, Sales Representative at Teva Canada

Teva’s 2021 Environmental, Social and Governance (ESG) Progress Report

Teva’s 2021 Environmental, Social and Governance (ESG) Progress Report

Meet Sylvie Forté, Teva Canada employee for over 30 years

Meet Sylvie Forté, Teva Canada employee for over 30 years

Meet Krishnaverny Sundararajah (Verny), Teva Canada employee for over 35 years

Meet Krishnaverny Sundararajah (Verny), Teva Canada employee for over 35 years

Meet Sean Steenson, Teva Canada employee for over 40 years

Meet Sean Steenson, Teva Canada employee for over 40 years

Teva’s Economic Impact Report

Teva’s Economic Impact Report
View all featured stories